Skip to content
OpenCapital
Get started

Upstream Bio, Inc. UPB Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$569K+14.3%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$852K-8.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$2.12M+8.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$328K-37.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$10.75M-0.5%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%—
Debt / equity0×0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s operating lease liabilities (current)?
Upstream Bio, Inc. (UPB) reported operating lease liabilities (current) of $724K in Q1 2026.
How has Upstream Bio, Inc.'s operating lease liabilities (current) changed year-over-year?
Upstream Bio, Inc.'s operating lease liabilities (current) increased by 2.3% year-over-year, from $708K to $724K.
What is the long-term trend for Upstream Bio, Inc.'s operating lease liabilities (current)?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s operating lease liabilities (current) has grown at a 300.0% compound annual growth rate (CAGR), from $45K to $720K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.